Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Deena Mary Atieh Graham"'
Autor:
Suzanne C. O’Neill, Claudine Isaacs, Filipa Lynce, Deena Mary Atieh Graham, Calvin Chao, Vanessa B. Sheppard, Yingjun Zhou, Chunfu Liu, Nandini Selvam, Marc D. Schwartz, Arnold L. Potosky
Publikováno v:
Breast Cancer Research, Vol 19, Iss 1, Pp 1-13 (2017)
Abstract Background Aside from chemotherapy utilization, limited data are available on the relationship between gene expression profiling (GEP) testing and breast cancer care. We assessed the relationship between GEP testing and additional variables
Externí odkaz:
https://doaj.org/article/e7dc401c4508464bba06cafc714520ce
Autor:
Melinda S. Hill, May D. Abdo-Matkiwsky, Noa Biran, Jumana Chatiwala, Aileen L. Chen, Julianne Wilkins Childs, Denis Fitzgerald, Deena Mary Atieh Graham, Ian Horkheimer, Rachel L. Levenbach, Joseph Francis McLaughlin, Kimberly A. Salwitz, Frederick P. Smith, Robert F. Tassan, Akunna J. Ejumejowo
Publikováno v:
Journal of Clinical Oncology. 40:e13543-e13543
e13543 Background: In February of 2020, Integra Connect (IC) released a machine learning (ML) risk prediction model called Integra Predict (IP) to predict End-of-Life (EOL) in active chemotherapy patients within the next six months. Pilot Study: Regi
Autor:
Stanley E, Waintraub, Donna, McNamara, Deena Mary Atieh, Graham, Andrew L, Pecora, John, Min, Tommy, Wu, Hyun Gi, Noh, Jacqueline, Connors, Ruth, Pe Benito, Kelly, Choi, Eric, Schultz, Stuart L, Goldberg
Publikováno v:
The American journal of managed care. 23(12)
Value-based payment reforms shift cost-containment responsibilities to the physician. Although gene expression profiling (GEP) utilizing a 21-gene panel among patients with early-stage, axillary lymph node-negative, hormone receptor-positive, HER2/ne